GuideRheumatology, allergy and dermatology
Relapsing polychondritis disease activity (RPDAI)
International consensus index that quantifies relapsing polychondritis activity over the previous 28 days.
Updated 3 November 2026
When to use it
Follow-up of patients with established relapsing polychondritis, to document activity and its change with treatment in clinic or in clinical studies.
Warning
The online scoring site cited in the original publication is no longer available (checked November 2026); item weights appear only in the original article.
What it is
The RPDAI was developed in 2012 through an international collaboration of 27 relapsing polychondritis experts. Items were chosen by consensus in a 4-round Delphi survey and their weights were estimated by regression against the physician global assessment (0–100 scale) of 43 test cases (1118 ratings).
Keep reading in the app
- What it assesses
- How to interpret it
- Limitations
Practical tip
It is not a diagnostic tool: diagnosis relies on clinical criteria (McAdam, Damiani, Michet) and on excluding other causes.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
